LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 116

Search options

  1. Article ; Online: The Practical Challenges of Making Clinical Use of the Quantitative Value for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load Across Several Dynamics.

    Mathers, Amy J

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 73, Issue 11, Page(s) e4206–e4207

    MeSH term(s) COVID-19 ; Diagnostic Tests, Routine ; Humans ; SARS-CoV-2 ; Serologic Tests ; Viral Load
    Keywords covid19
    Language English
    Publishing date 2020-07-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciaa958
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reply to Davis et al.

    Tamma, Pranita D / Mathers, Amy J / Wenzler, Eric

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2023  Volume 77, Issue 1, Page(s) 163–165

    Language English
    Publishing date 2023-03-23
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciad170
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.

    Bryson, Alexandra L / Bhalodi, Amira / Liesman, Rachael M / Mathers, Amy J

    Journal of clinical microbiology

    2024  Volume 62, Issue 4, Page(s) e0078821

    Abstract: Traditionally, cephalothin susceptibility results were used to predict the susceptibility of additional cephalosporins; however, in 2013-2014, the Clinical and Laboratory Standards Institute (CLSI) revisited this practice and determined that cefazolin is ...

    Abstract Traditionally, cephalothin susceptibility results were used to predict the susceptibility of additional cephalosporins; however, in 2013-2014, the Clinical and Laboratory Standards Institute (CLSI) revisited this practice and determined that cefazolin is a more accurate proxy than cephalothin for uncomplicated urinary tract infections (uUTIs). Therefore, a cefazolin surrogacy breakpoint was established to predict the susceptibility of seven oral cephalosporins for
    MeSH term(s) Humans ; Cefazolin/pharmacology ; Cefazolin/therapeutic use ; Cephalosporins/pharmacology ; Cephalothin ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Microbial Sensitivity Tests ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/microbiology ; Escherichia coli ; Monobactams
    Chemical Substances Cefazolin (IHS69L0Y4T) ; Cephalosporins ; Cephalothin (R72LW146E6) ; Anti-Bacterial Agents ; Monobactams
    Language English
    Publishing date 2024-03-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/jcm.00788-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales.

    Mathers, Amy J / Lewis, James S

    JAC-antimicrobial resistance

    2021  Volume 3, Issue 2, Page(s) dlab020

    Abstract: Phenotypic testing for Enterobacterales that harbour ESBLs is not additive to ... ...

    Abstract Phenotypic testing for Enterobacterales that harbour ESBLs is not additive to accurate
    Language English
    Publishing date 2021-05-07
    Publishing country England
    Document type Journal Article ; Comment
    ISSN 2632-1823
    ISSN (online) 2632-1823
    DOI 10.1093/jacamr/dlab020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Navigating treatment approaches for presumed ESBL-producing infections.

    Tamma, Pranita D / Mathers, Amy J

    JAC-antimicrobial resistance

    2021  Volume 3, Issue 1, Page(s) dlaa111

    Abstract: ESBL-producing Enterobacterales (ESBL-E) remain a significant global threat. In several regions of the world, ESBLs are produced by over half ... ...

    Abstract ESBL-producing Enterobacterales (ESBL-E) remain a significant global threat. In several regions of the world, ESBLs are produced by over half of
    Language English
    Publishing date 2021-02-24
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2632-1823
    ISSN (online) 2632-1823
    DOI 10.1093/jacamr/dlaa111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics

    Mathers, Amy J

    Clinical Infectious Diseases ; ISSN 1058-4838 1537-6591

    2020  

    Keywords Microbiology (medical) ; Infectious Diseases ; covid19
    Language English
    Publisher Oxford University Press (OUP)
    Publishing country uk
    Document type Article ; Online
    DOI 10.1093/cid/ciaa958
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach.

    Pierce, Virginia M / Mathers, Amy J

    Journal of the Pediatric Infectious Diseases Society

    2021  Volume 11, Issue 2, Page(s) 73–80

    Abstract: Breakpoints are the values used by clinical microbiology laboratories to interpret the results of antimicrobial susceptibility testing (AST) and classify isolates as susceptible or resistant. Whether the breakpoints applied by laboratories accurately ... ...

    Abstract Breakpoints are the values used by clinical microbiology laboratories to interpret the results of antimicrobial susceptibility testing (AST) and classify isolates as susceptible or resistant. Whether the breakpoints applied by laboratories accurately predict the likelihood of successful treatment with a particular antimicrobial is an issue of critical importance to quality clinical care. In the United States, the Food and Drug Administration (FDA) sets breakpoints, and globally, breakpoints are also set by 2 standards development organizations, the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST); individual laboratories may choose which breakpoints to implement. Many CLSI breakpoints are recognized by FDA, facilitating their incorporation into widely used commercial AST devices. The CLSI Subcommittee on AST's consensus approach to establishing (and as needed, revising) breakpoints involves integration of currently available microbiological, pharmacokinetic-pharmacodynamic, and clinical data. Here, an overview of the CLSI process for establishing breakpoints is provided.
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Child ; Communicable Diseases/drug therapy ; Humans ; Laboratories ; Microbial Sensitivity Tests ; United States
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2021-11-23
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piab106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Successful Treatment of Persistent

    Hsu, Alice J / Simner, Patricia J / Bergman, Yehudit / Mathers, Amy J / Tamma, Pranita D

    Open forum infectious diseases

    2023  Volume 10, Issue 4, Page(s) ofad174

    Abstract: Stenotrophomonas ... ...

    Abstract Stenotrophomonas maltophilia
    Language English
    Publishing date 2023-03-29
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2757767-3
    ISSN 2328-8957
    ISSN 2328-8957
    DOI 10.1093/ofid/ofad174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Disk Correlates for Revised Clinical and Laboratory Standards Institute

    Humphries, Romney / Tamma, Pranita D / Mathers, Amy J

    Journal of clinical microbiology

    2022  Volume 60, Issue 5, Page(s) e0024322

    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Humans ; Microbial Sensitivity Tests ; Piperacillin, Tazobactam Drug Combination/pharmacology ; Pseudomonas aeruginosa
    Chemical Substances Anti-Bacterial Agents ; Piperacillin, Tazobactam Drug Combination (157044-21-8)
    Language English
    Publishing date 2022-04-21
    Publishing country United States
    Document type Letter
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/jcm.00243-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top